ID: ALA2206365

Max Phase: Preclinical

Molecular Formula: C22H28O3

Molecular Weight: 340.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCc1ccc(CCc2cc(O)ccc2C(=O)O)cc1

Standard InChI:  InChI=1S/C22H28O3/c1-2-3-4-5-6-7-17-8-10-18(11-9-17)12-13-19-16-20(23)14-15-21(19)22(24)25/h8-11,14-16,23H,2-7,12-13H2,1H3,(H,24,25)

Standard InChI Key:  ACAUUECSDGFIBA-UHFFFAOYSA-N

Associated Targets(non-human)

LOX1.1 Seed lipoxygenase-1 (463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 340.46Molecular Weight (Monoisotopic): 340.2038AlogP: 5.39#Rotatable Bonds: 10
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.21CX Basic pKa: CX LogP: 7.04CX LogD: 4.02
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.57Np Likeness Score: 0.56

References

1. Wisastra R, Ghizzoni M, Boltjes A, Haisma HJ, Dekker FJ..  (2012)  Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.,  20  (16): [PMID:22789707] [10.1016/j.bmc.2012.06.019]

Source